Medicis Pharmaceutical Corp. (MRX) Tops Q1 EPS by 14c
Tweet
Share
E-mailGet Alerts MRX Hot Sheet
Price: $65.75 -0.15%
EPS Growth %: +22.5%
Financial Fact:
Diluted net income (loss) per share: 0.02
Today's EPS Names:
FCNCA, PBCO, ARBV, More
EPS Growth %: +22.5%
Financial Fact:
Diluted net income (loss) per share: 0.02
Today's EPS Names:
FCNCA, PBCO, ARBV, More
Join SI Premium – FREE
Medicis Pharmaceutical Corp. (NASDAQ: MRX) reported Q1 EPS of $0.91, $0.14 better than the analyst estimate of $0.77. Revenue for the quarter came in at $467.3 million versus the consensus estimate of $428.46 million.
For earnings history and earnings-related data on Medicis Pharmaceutical Corp. (MRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bleecker Street Research is short Lyft (LYFT)
- Freeport-McMoran (FCX) Tops Q2 EPS by 15c
- Norfolk Southern (NSC) Tops Q2 EPS by 29c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
